Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $62.1 million.

  • Gossamer Bio's Total Current Liabilities rose 2159.54% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 2159.54%. This contributed to the annual value of $45.0 million for FY2024, which is 1276.79% down from last year.
  • As of Q3 2025, Gossamer Bio's Total Current Liabilities stood at $62.1 million, which was up 2159.54% from $53.6 million recorded in Q2 2025.
  • Gossamer Bio's Total Current Liabilities' 5-year high stood at $62.1 million during Q3 2025, with a 5-year trough of $34.6 million in Q1 2022.
  • Its 4-year average for Total Current Liabilities is $46.4 million, with a median of $45.2 million in 2024.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 1962.01% in 2023, then soared by 3462.97% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Total Current Liabilities stood at $49.2 million in 2022, then increased by 4.81% to $51.6 million in 2023, then dropped by 12.77% to $45.0 million in 2024, then skyrocketed by 38.01% to $62.1 million in 2025.
  • Its Total Current Liabilities stands at $62.1 million for Q3 2025, versus $53.6 million for Q2 2025 and $48.2 million for Q1 2025.